Literature DB >> 23132874

Changing epidemiology of hepatitis B and migration--a comparison of six Northern and North-Western European countries.

Janet JunQing Chu1, Tanja Wörmann, Johann Popp, Gunnar Pätzelt, Manas K Akmatov, Alexander Krämer, Ralf Reintjes.   

Abstract

BACKGROUND: Increased migration volume and different Hepatitis B prevalence between immigration and emigration countries have changed the Hepatitis B virus (HBV) epidemiology considerably in Northern and North-Western European migrants-receiving countries. Due to the difference in migration status monitoring, the HBV infection data on migrants are not easily comparable among those countries. The study aims were: to compare the migration status indicators used by the national surveillance system in six Northern and North-Western European countries (the Netherlands, Germany, Finland, Denmark, Sweden and the UK); to determine the impact of the migration status on HBV infection by comparing the available data on prevalence and transmission routes of Hepatitis B in the migration and the general population in the six countries; to recommend sensible indicators and pertinent measures for HBV infection surveillance and control in the region.
METHODS: Literature review, statistical data analysis on migration and HBV infection in the six countries; expert interviews to identify migration status indicators used in national surveillance systems.
RESULTS: Evident differences were found between the migration and the general population in Hepatitis B prevalence and transmission routes in the six countries. Migration status is monitored differently in six surveillance systems; immigrants from high/intermediate Hepatitis B endemic countries constitute a substantial proportion of HBsAg(+) and chronic cases in all six countries.
CONCLUSIONS: International migration has an obvious impact on Hepatitis B prevalence in the six countries. It is important to include common migration status indicators and to collect comparable data for HBV infection surveillance in different notification systems.

Entities:  

Mesh:

Year:  2012        PMID: 23132874     DOI: 10.1093/eurpub/cks067

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  20 in total

Review 1.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

2.  Epidemiology of chronic hepatitis B virus in Ireland using routinely collected surveillance and administrative data, 2004-2014.

Authors:  Caroline E van Gemert; Niamh Murphy; Tara A Mitchell; Margaret E Hellard; Lelia Thornton
Journal:  Ir J Med Sci       Date:  2017-12-09       Impact factor: 1.568

Review 3.  Optimizing antiviral agents for hepatitis B management in malignant lymphomas.

Authors:  Oluwatobi O Ozoya; Julio Chavez; Lubomir Sokol; Samir Dalia
Journal:  Ann Transl Med       Date:  2017-02

Review 4.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

5.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

6.  Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey.

Authors:  Angela Bechini; Abby Falla; Amena Ahmad; Irene Veldhuijzen; Sara Boccalini; Barbara Porchia; Miriam Levi
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

Review 7.  Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review.

Authors:  John A Owiti; Trisha Greenhalgh; Lorna Sweeney; Graham R Foster; Kamaldeep S Bhui
Journal:  BMC Public Health       Date:  2015-02-15       Impact factor: 3.295

8.  Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013.

Authors:  Barbara Stawinska-Witoszynska; Monika Zysnarska; Małgorzata Krzywinska-Wiewiorowska; Paulina Wojtyła-Buciorab; Alicja Krzyzaniak; Barbara Wieckowska
Journal:  Hepat Mon       Date:  2016-07-25       Impact factor: 0.660

9.  Timing of chronic hepatitis B diagnosis after migration and its determinants among Sub-Saharan African migrants living in France.

Authors:  Julie Pannetier; Virginie Gigonzac; Nathalie Lydié; Annabel Desgrées du Loû; Rosemary Dray Spira
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

10.  Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area.

Authors:  Chen-Hsuan Wu; Te-Yao Hsu; Fu-Tsai Kung; Chan-Chao ChangChien; Ching-Chang Tsai; Sheng-Nan Lu
Journal:  Sci Rep       Date:  2017-04-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.